NCT06672133View on ClinicalTrials.gov

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

524

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 30, 2029

Study Completion Date

December 31, 2029

Conditions

Extensive Stage Lung Small Cell Carcinoma

Interventions

DRUG

Adebrelimab

Given：IV

RADIATION

Radiation Therapy

Undergo radiation therapy

All Listed Sponsors

lead

Jinming Yu

OTHER